DelveInsight’s “DNA Microarray Market Insights, Epidemiology, and Market Forecast-2034” report offers an in-depth understanding of the DNA Microarray market, historical and forecasted trends as well as the DNA Microarray market dynamics in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To Know in detail about the DNA Microarray market outlook, drug uptake, treatment scenario and trends, Click here; DNA Microarray Market Forecast
Some of the key facts of the DNA Microarray Market Report:
- In May 2025, Agilent Technologies received European regulatory approval for its SurePrint G3 Human CNV Microarray, expanding its clinical and research applications across European markets.
- In May 2025, Illumina secured approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for its TruSight Oncology Comprehensive test, supporting more efficient pan-tumor profiling in clinical practice.
- In April 2025, Eurofins Genomics expanded its service capabilities by acquiring the Sanger sequencing business of LGC Group.
- The DNA Microarray market size was valued at approximately USD 2,596.21 million in 2025 and is anticipated to reach USD 4,797.63 million by 2034, growing at a CAGR of 7.11% during the study period (2026-2034).
- In 2025, North America accounted for the largest DNA Microarray market share at approximately 41.39%, driven by strong presence of leading biotechnology companies and advanced healthcare infrastructure.
- In the Microarray type segment, oligonucleotide DNA Microarrays dominated with approximately 61.32% market share in 2025, due to their high specificity, reproducibility, and scalability in genomic analysis.
- In the application segment, gene expression analysis is projected to dominate with around 53.42% of the market share in 2025, owing to its critical role in understanding disease mechanisms and enabling precision medicine.
- According to the World Health Organization (2026) and the International Agency for Research on Cancer (IARC), new cancer cases were projected to reach 21,325,245 in 2025, increasing to 35,281,056 by 2050, significantly driving demand for DNA Microarrays.
- The anticipated launch of advanced DNA Microarray platforms with improved sensitivity, faster processing times, and enhanced data analysis capabilities is expected to drive growth in the total DNA Microarray market in the coming years.
- Key DNA Microarray Companies: Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, PerkinElmer, Merck KGaA, F. Hoffmann-La Roche Ltd., Arrayit Corporation, Phalanx Biotech Group, CapitalBio Corporation, Applied Microarrays, LC Sciences, Oxford Gene Technology, Akonni Biosystems, Arraystar Inc., Febit Holding GmbH, CustomArray Inc., Microarrays Inc., Molecular Devices, Scienion AG, and others.
- Key DNA Microarray Products/Technologies: Axiom™ PangenomiX Array, Applied Biosystems™ CytoScan™ HD Accel array, SurePrint G3 Human CNV Microarray, Affymetrix GeneChip™ arrays, SurePrint G3 oligonucleotide Microarrays, Infinium™ BeadChips, and others.
- The DNA Microarray market is expected to surge due to the rising prevalence of genetic and chronic diseases, increased adoption in drug discovery and development, and continuous product innovations during the forecast period.
DNA Microarray Overview
A DNA Microarray is a laboratory tool used to analyze the expression of thousands of genes simultaneously. It consists of a solid surface, such as a glass slide or chip, onto which numerous DNA probes are fixed in a grid pattern. When a labeled DNA or RNA sample is applied, complementary sequences bind to these probes, allowing researchers to measure gene activity, detect mutations, and study genetic variations in a high-throughput and efficient manner.
DNA Microarrays are widely used in gene expression profiling, mutation detection, biomarker discovery, cancer research, drug development, and personalized medicine applications.
Get a Free sample for the DNA Microarray Market Forecast, Size & Share Analysis Report
DNA Microarray Market Insights
The market insights section provides a comprehensive analysis of the DNA Microarray market trends, including technological advancements, regulatory landscape, and competitive dynamics across major markets.
DNA Microarray Market Segmentation:
The DNA Microarray market report provides detailed segmentation for the study period 2023-2034 across the following categories:
- Product Type: Instruments, Consumables, Software, and Services
- Microarray Type: cDNA Microarrays, Oligonucleotide DNA Microarrays, SNP (Single Nucleotide Polymorphism) Microarrays, and Comparative Genomic Hybridization (CGH) Microarrays
- Application: Gene Expression Analysis, Genotyping & SNP Analysis, and Others
- End-Users: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
- Geography: North America, Europe, Asia-Pacific, and Rest of the World
Download the report to understand which factors are driving DNA Microarray market trends @ DNA Microarray Market Segmentation
DNA Microarray Market Uptake and Technology Development Activities
The market uptake section focuses on the adoption rate of recently launched DNA Microarray platforms and technologies expected to enter the market during the study period. The analysis covers market uptake by technology, adoption by end-users, and revenue generation.
Moreover, the technology assessment section helps understand which platforms demonstrate the most rapid uptake and the reasons behind their widespread adoption. Additionally, it compares technologies based on market share and clinical utility.
The report also covers DNA Microarray Development Activities, providing valuable insights about different technologies in various development stages and key companies involved in advancing targeted platforms. It analyzes recent developments such as collaborations, acquisitions, mergers, licensing, patent details, and other information for emerging technologies.
DNA Microarray Technology and Key Companies
- Axiom™ PangenomiX Array: Thermo Fisher Scientific
- Applied Biosystems™ CytoScan™ HD Accel array: Thermo Fisher Scientific
- SurePrint G3 Human CNV Microarray: Agilent Technologies
- Affymetrix GeneChip™ arrays: Thermo Fisher Scientific
- SurePrint G3 oligonucleotide Microarrays: Agilent Technologies
- Infinium™ BeadChips: Illumina
Discover more about technologies set to grab major DNA Microarray market share @ DNA Microarray Companies
DNA Microarray Market Drivers
- Rising global prevalence of cancer, cardiovascular disorders, and genetic diseases driving demand for gene expression profiling and mutation detection
- Growing adoption in drug discovery and development for biomarker identification and drug response analysis
- Advancements in high-throughput, cost-effective platforms with improved sensitivity and data analysis capabilities
- Increasing healthcare expenditure and government funding for genomics research
- Expansion of precision medicine and personalized treatment approaches
- Strong presence of leading biotechnology and pharmaceutical companies investing in genomic technologies
- Integration with AI and machine learning for enhanced data analysis and clinical decision support
DNA Microarray Market Barriers
- High cost of instruments, consumables, and data analysis limiting adoption in smaller laboratories
- Strong competition from next-generation sequencing (NGS) and other advanced genomic technologies
- Stringent data privacy regulations governing clinical genomic data sharing
- Limited awareness and technical expertise in developing regions
- Complexity in data interpretation requiring specialized bioinformatics support
- Preference shift toward more flexible and comprehensive sequencing platforms
- Regulatory challenges and lengthy approval processes for clinical applications
Scope of the DNA Microarray Market Report
- Study Period: 2023-2034
- Coverage: 7MM
- Key DNA Microarray Companies: Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, PerkinElmer, Merck KGaA, Roche, Arrayit Corporation, Phalanx Biotech Group, CapitalBio Corporation, Applied Microarrays, LC Sciences, Oxford Gene Technology, Akonni Biosystems, Arraystar Inc., Febit Holding GmbH, CustomArray Inc., Microarrays Inc., Molecular Devices, Scienion AG, and others.
- DNA Microarray Technology Assessment: Current marketed and emerging DNA Microarray platforms
- DNA Microarray Market Dynamics: Market drivers and market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- DNA Microarray Unmet Needs, KOL’s views, Analyst’s views, Market Access and Reimbursement
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm exclusively focused on life sciences. We empower pharmaceutical and biotech companies with robust, end-to-end solutions for enhancing strategic decision-making and performance. Our Healthcare Consulting Services leverage market intelligence to drive growth and resolve challenges with an actionable, practical approach.
Contact Information
Kanishk
kkumar@delveinsight.com
